Chemical Modifications of Pyridoxine for Biological Applications : An Overview
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Pyridoxine and its derivatives, pyridoxamine, and pyridoxal have been recognized for more than 70 years and are known for regulating cellular biology and metabolism. During the past few decades, the anti-oxidant and anti-inflammatory properties of pyridoxine and its vitamers were explored. However, an interesting turnabout was observed in pyridoxine chemical modification in the last two decades. The various important pathophysiological aspects of pyridoxine and its derivatives on several cellular systems have been discovered by researchers. Recent findings have shown that many diseases, like cancer, diabetes, hypertension, tuberculosis, epilepsy, and neurodegenerative diseases are linked to the alteration of pyridoxine. Herein, our main focus is to review the importance of pyridoxine and its derivatives obtained by various chemical modifications, in various disease areas and to recognize important directions for future research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Current topics in medicinal chemistry - 23(2023), 2 vom: 07., Seite 98-113 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pawar, Rajashree [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3THM379K8A |
|---|
| Anmerkungen: |
Date Completed 27.03.2023 Date Revised 27.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1568026623666221208125203 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350156638 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350156638 | ||
| 003 | DE-627 | ||
| 005 | 20231226044339.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1568026623666221208125203 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1167.xml |
| 035 | |a (DE-627)NLM350156638 | ||
| 035 | |a (NLM)36503471 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pawar, Rajashree |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chemical Modifications of Pyridoxine for Biological Applications |b An Overview |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.03.2023 | ||
| 500 | |a Date Revised 27.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Pyridoxine and its derivatives, pyridoxamine, and pyridoxal have been recognized for more than 70 years and are known for regulating cellular biology and metabolism. During the past few decades, the anti-oxidant and anti-inflammatory properties of pyridoxine and its vitamers were explored. However, an interesting turnabout was observed in pyridoxine chemical modification in the last two decades. The various important pathophysiological aspects of pyridoxine and its derivatives on several cellular systems have been discovered by researchers. Recent findings have shown that many diseases, like cancer, diabetes, hypertension, tuberculosis, epilepsy, and neurodegenerative diseases are linked to the alteration of pyridoxine. Herein, our main focus is to review the importance of pyridoxine and its derivatives obtained by various chemical modifications, in various disease areas and to recognize important directions for future research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Chemical modification | |
| 650 | 4 | |a Pyridoxal | |
| 650 | 4 | |a Pyridoxamine | |
| 650 | 4 | |a Pyridoxine | |
| 650 | 4 | |a Pyridoxine derivatives | |
| 650 | 4 | |a Vitamin B6 | |
| 650 | 7 | |a Pyridoxal |2 NLM | |
| 650 | 7 | |a 3THM379K8A |2 NLM | |
| 650 | 7 | |a Pyridoxamine |2 NLM | |
| 650 | 7 | |a 6466NM3W93 |2 NLM | |
| 650 | 7 | |a Pyridoxine |2 NLM | |
| 650 | 7 | |a KV2JZ1BI6Z |2 NLM | |
| 700 | 1 | |a Chaudhran, Preeti |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Dheeraj |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Abha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d 2001 |g 23(2023), 2 vom: 07., Seite 98-113 |w (DE-627)NLM117790141 |x 1873-4294 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:2 |g day:07 |g pages:98-113 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1568026623666221208125203 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 2 |b 07 |h 98-113 | ||